← Leaderboards
Bridget Marie Barker
University Of California, San Francisco
$4,599,845
Attributed
$4,900,900
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,900,900 · 9
By mechanism
U19$3,770,936 · 6
R21$859,182 · 2
K22$270,782 · 1
Top collaborators
- Donald G Catanzaro2 shared
- Joseph Wang2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Anita Sil$24,389,913
- George Richard Thompson$922,823
- Katrina K Hoyer$2,320,998
- Clarissa Jane Nobile$4,472,394
- Sara Vazquez$183,414
Others in their field
Top investigators on “Coccidioidomycosis”
- Susanna Naggie · Duke University$17,352,697
- John N Galgiani · Veterans Medical Research Fdn/San Diego$10,416,305
- Garry Thomas Cole · Veterans Medical Research Fdn/San Diego$5,455,899
- Justin V Remais · University Of California Berkeley$5,431,125
- Chiung-Yu Hung · University Of Texas San Antonio$5,101,104
- Anita Sil · University Of California, San Francisco$4,260,384
Research focus
CoccidioidomycosisDesert FeverCoccidioidesInfectionCoccidioides PosadasiiCoccidioides ImmitisVirulenceAntigensDiagnosticProteinsGene DeletionIncidenceVirulence FactorsVaccinesIn VitroReportingIn VivoGenesVaccine DevelopmentCrispr/Cas TechnologyImmune ResponseTranscriptPathogenic FungusPathogen
Grant awards (19)
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$314,647
U19 · FY2025 · AI · contact PI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$272,719
U19 · FY2025 · AI · contact PI
CRISPR and Virulence Core$267,137
U19 · FY2025 · AI · contact PI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$264,312
U19 · FY2025 · AI · contact PI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$484,205
U19 · FY2024 · AI · contact PI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$246,259
U19 · FY2024 · AI · contact PI
CRISPR and Virulence Core$210,190
U19 · FY2024 · AI · contact PI
Rational design of a novel rapid diagnostic tool for coccidioidomycosis$195,569
R21 · FY2024 · AI · contact PI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$452,916
U19 · FY2023 · AI · contact PI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$276,453
U19 · FY2023 · AI · contact PI
Rational design of a novel rapid diagnostic tool for coccidioidomycosis$256,013
R21 · FY2023 · AI · contact PI
CRISPR and Virulence Core$213,876
U19 · FY2023 · AI · contact PI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$274,735
U19 · FY2022 · AI · contact PI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$263,199
U19 · FY2022 · AI · contact PI
CRISPR and Virulence Core$230,288
U19 · FY2022 · AI · contact PI
Defining the Mechanisms of Recombination in Coccidioides$190,000
R21 · FY2019 · AI · contact PI
Defining the Mechanisms of Recombination in Coccidioides$217,600
R21 · FY2018 · AI · contact PI
Functional Analysis of Regions of Introgression Between Species of Coccidioides$106,895
K22 · FY2015 · AI · contact PI
Functional Analysis of Regions of Introgression Between Species of Coccidioides$163,887
K22 · FY2014 · AI · contact PI